🆕publication in nature communications! Blood #multiomics revealed molecular networks linking lipid mediators, mitochondrial dysfunction and inflammation with progression to #ACLF and short-term mortality. 🔓 www.nature.com/articles/s41... #Hepatology #LiverSky

🎥First insight into 𝗪𝗣𝟲 - 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀 𝗳𝗼𝗿 #𝗔𝗙𝗯𝘂𝗿𝗱𝗲𝗻 𝗿𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗯𝘆 #𝗖𝗜𝗘𝗗 𝗣𝗿𝗼𝗳. 𝗦𝘁𝗲𝘃𝗲𝗻 speaks with 𝗣𝗗 𝗗𝗿. 𝗡𝗶𝗻𝗮 𝗕𝗲𝗰𝗵𝗲𝗿, about the goals of WP6, led by 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗲𝗿 𝗛𝗮𝗺𝗯𝘂𝗿𝗴-𝗘𝗽𝗽𝗲𝗻𝗱𝗼𝗿𝗳 - 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗛𝗲𝗮𝗿𝘁 & 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗲𝗻𝘁𝗲𝗿 𝗛𝗮𝗺𝗯𝘂𝗿𝗴 together with 𝗕𝗶𝗼𝘁𝗿𝗼𝗻𝗶𝗸. 👉 Full video: youtu.be/vnRiTcnl7r0

🤝Meaningful #PatientEngagement in research has to be built in from the start. Hear how the GREG project implemented a systematic approach to patient involvement including a workshop for researchers on how to best engage with patients for impactful results. 👉 bit.ly/4pQSx7a #PatientsInResearch

🎥First insights into 𝗪𝗣𝟱 - 𝗘𝗳𝗳𝗲𝗰𝘁𝘀 𝗼𝗳 #𝗔𝗙𝗯𝘂𝗿𝗱𝗲𝗻 𝗼𝗻 𝗯𝗿𝗼𝗮𝗱 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗣𝗿𝗼𝗳. 𝗦𝘁𝗲𝘃𝗲𝗻 talks with 𝗣𝗿𝗼𝗳. 𝗦𝗰𝗵𝗻𝗮𝗯𝗲𝗹 about the objectives of WP5, led by University Medical Center Hamburg-Eppendorf - University Heart & Vascular Center Hamburg together with Acesion. 👉 Full #AFBSTEP video: youtu.be/xeX4t2D1Tjo

We were shocked and saddened by the attacks at Berlin's Pride Festival on Saturday, and send our love and support to everyone who has been affected, including our colleagues at Charité. Everyone involved in SP-EU stands with LGBTIQ+ communities during this difficult time.

🎥 𝗪𝗣𝟰: 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗔𝗙 𝗯𝘂𝗿𝗱𝗲𝗻 𝗼𝗻 𝘀𝘁𝗿𝗼𝗸𝗲, 𝗵𝗲𝗮𝗿𝘁 𝗳𝗮𝗶𝗹𝘂𝗿𝗲, 𝗮𝗻𝗱 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗲𝗮𝘁𝗵 𝗨𝗞𝗘 - 𝗜𝗠𝗕𝗘 leads WP4 together with @novartis.bsky.social. Prof. Zapf, Dr. Heinrich, and Dr. Sehner discuss with Prof. Steven the statistical challenges and opportunities of understanding #AFburden. 👉 youtu.be/4gW1cgINZYs

🆕 publication in #EUHeartJ: doi.org/10.1093/eurh... 🧬 Nano- & #microplastics emerge as cardiovascular #riskfactor 🔬 Plastic particles may damage cardiovascular system by promoting oxidative stress, inflammation, endothelial dysfunction, thrombosis, and vascular injury @escardio.bsky.social

Growing evidence suggests #ADHD may be linked to long-term cardiometabolic health, incl. cholesterol, blood pressure, #obesity and CVD. Recently, in #BBC Science Focus feature, Prof. Stephen Faraone explains that this relationship is likely shaped by a mix of genetics, lifestyle and biology.

🌍 environMENTAL General Assembly Meeting 2026 🌍 This month, the environMENTAL Consortium held its Annual General Assembly Meeting in Cadenabbia, Italy. Thanks to all who attended for making the meeting so productive 🙏

📣 Just out: onlinelibrary.wiley.com/doi/10.1002/... We show that oral–gut microbial translocation in advanced cirrhosis drives metabolic convergence and increased ammonia & acetate production, linking the microbiome to systemic metabolic stress. 🧠🔬 #Cirrhosis #Microbiome #Hepatology #LiverDisease

📢 Save the date! ➡️ 15th International Congress on Liquid Biopsy 2027 ( #ISMRC2027 ) When 📆: 12 - 14 May 2027 Where 📍: Palma de Mallorca, Spain More info ℹ️: tacticsmd.net/congreso/ism... #SaveTheDate #Conference #LiquidBiopsy

📢 #PUBLICATION #ALERT 𝗔𝗶𝗿 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗺𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝗲𝘅𝗽𝗼𝘀𝘂𝗿𝗲 𝘁𝗼 𝘂𝗹𝘁𝗿𝗮𝗳𝗶𝗻𝗲 𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗽𝗼𝗹𝗹𝘂𝘁𝗶𝗼𝗻 by Jos Lelieveld et al. 🔗 academic.oup.com/cardiovascre... 🎯 Highlights substantial health burden posed by ultrafine particle pollution 🎯 Targeted measures to reduce emissions #MarkersOfPollution

MARKOPOLO at the 5th International Workshop on Public Policy by International #PublicPolicy Association (IPPA) in Ottawa! In the Workshop " #WickedProblems and Evidence-Based Policy", Ulrike Zeigermann and Christoph Mohamad-Klotzbach presented the study "Boundary spanning in #EnvironmentalHealth"

👏 Looking back: What a fantastic #EASLCongress 2026! 💪 50+ talks, posters, sessions & symposia, with outstanding work from early-career scientists. ✨ Main highlights: The MICROB-PREDICT Consensus Conference & Networking Session 🎉Congratulations to the whole team! #ACLF #microbiome #cirrhosis

📣 A major milestone for the A-TANGO project: The first patient with #ACLF has started treatment in the Phase 2 trial evaluating the investigational #G-TAK combination therapy. A crucial step towards developing new treatment options for this life-threatening condition! 🔗 a-tango.eu/wp-content/u...

📣🏃 Here's a practical roadmap to make daily exercise part of routine childhood cancer care! Our new FORTEe consensus paper provides key practical recommendations for implementing safe, scalable exercise therapy in #PediatricOncology. 🔗 www.frontiersin.org/journals/onc... #Exercise #SupportiveCare

📣 Just published: Making exercise more motivating for children + young adults during cancer treatment!🤾 👉 Motion-tracking technology & personalised programmes 🔗 Find out more: www.frontiersin.org/journals/ped... #ChildhoodCancer #DigitalHealth #ExerciseOncology #GetStrongToFightChildhoodCancer

Do you live with #ChronicPain? 👉 Take this short survey: lnkd.in/e3XT8YPK 🙂 Share your views on #painmanagement, satisfaction, #SideEffects, and what you value most from your pain medication. ☝ Every #patient experience is different. 🦻 We want to hear your voice! #painresearch #painrelief

🎥 𝗪𝗣𝟮 – 𝗗𝗮𝘁𝗮 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 & 𝗛𝗮𝗿𝗺𝗼𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗗𝗿. 𝗢𝗯𝗲𝗿𝗴𝗮𝘀𝘀𝗲𝗹 (𝗨𝗞𝗘, 𝗪𝗣𝟮 𝗟𝗲𝗮𝗱) speaks about integrating diverse AF datasets across #AFBSTEP: centralized data management, prospective studies & building the largest, highly-integrated AF dataset. 👉 Full interview: youtu.be/ZZ2GogF4cRM #AFburden #DataScience

🎥Insights from 𝗪𝗣𝟯 - 𝗖𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗙 𝗯𝘂𝗿𝗱𝗲𝗻 𝗣𝗿𝗼𝗳. 𝗦𝗰𝗵𝗼𝘁𝘁𝗲𝗻 @maastrichtu.bsky.social speaks with Prof. Steven about the challenges of accurately characterising AF burden across diverse patient populations and monitoring technologies. 👉 Full interview: youtu.be/oN7j6EqUfdY #AFBSTEP #AFburden

🎉 DECISION video series complete! 💯 Explore short explainers on #cirrhosis, #ACLF, immune dysfunction, epigenetics, extracellular vesicles, single-cell technologies, and MASH research. 🎥 Full playlist: www.youtube.com/playlist?lis... #LiverDisease #SciComm

This week, the PANCAID Steering Committee met virtually to review progress, discuss activities, and align on priorities. The next months will be both busy and exciting as we work together to maximise the project's scientific, clinical, and societal impact. #PancreaticCancer #LiquidBiopsy

🤝 Collaboration is key. AF-B-STEP unites 18 partners with one goal: redefining atrial fibrillation — from “yes” or “no” to what really matters. 👉 We will introduce our partners and highlight their role within the consortium— stay tuned. #AFBSTEP #AFib #AFBurden #Collaboration #EUResearch

Great to be part of #EHRA2026 in #Paris! We presented 𝗔𝗙-𝗕-𝗦𝗧𝗘𝗣, an international project aiming to better understand and quantify #AFBurden and its impact on outcomes such as stroke, heart failure, and quality of life. Thanks to everyone who joined 🙏 #AFBSTEP #AtrialFibrillation #EUResearch #IHI

⭐𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 - 𝗠𝗲𝗱𝘁𝗿𝗼𝗻𝗶𝗰 As a leader in cardiac rhythm management, Medtronic brings valuable industrial & translational expertise to #AFBSTEP. 👉Learn more about contribution and role: www.linkedin.com/feed/update/... 👉Full interview with Project Lead Mirko de Melis: www.youtube.com/@AF-B-STEP

We sat down with 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗖𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗼𝗿 Prof. Paulus Kirchhof about the vision, the ambition — and the challenges — behind the AF-B-STEP project. 👉 Watch the full interview on YouTube: youtu.be/dd9duRHisRk #AFBSTEP #AFBurden #AFib #EUresearch #IHI

What happens before cirrhosis patients suddenly deteriorate? 🪫 Single-cell analysis reveals that monocytes lose energy before organ failure, a signal linked to infections, disease progression, and survival. 🎥 Watch: youtu.be/D1aH-RC6DsM #LiverSky #cirrhosis #liverdisease

🎥 𝗜𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 𝘄𝗶𝘁𝗵 𝗣𝗿𝗼𝗳. 𝗝𝗼𝗵𝗻 𝗖𝗮𝗺𝗺 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗘𝘁𝗵𝗶𝗰𝘀 𝗔𝗱𝘃𝗶𝘀𝗼𝗿𝘆 𝗕𝗼𝗮𝗿𝗱 (EAB) The EAB, comprising J. Camm, J. Piccini, and S. Gilbert, guiding AF-B-STEP on all ethics matters to ensure the highest scientific standards and the best outcomes for patients. 👉 Full interview on YouTube: youtu.be/49T_rKnX5yc

Why ELPA is going on a unique European Liver Screening Tour ELPA is going on a unique European Liver Screening Tour because Europe can no longer afford to wait for liver disease to become visible only when it is already advanced. For too long, liver disease has remained silent.